Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Name: Puma Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Puma Biotechnology Inc
Rating: 1.8590555
Author: Trendlyne DVM scores

Risky Value

about

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

6.76 -0.05 (-0.73%)

123.10% Gain from 52W Low

49,188.5

XNAS Volume

XNAS 19 May, 2026 10:56 AM (EDT)

Low Financial Strength

22.2 / 100

Affordable Valuation

52.0 / 100

Technically Neutral

52.3 / 100

Risky Value These stocks have weak financials and average momentum. They may be affordable, but investors should exercise caution View Similar Embed DVM

1Yr Price target downside is -26%

1 analysts

Puma biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

123.10% Gain from 52W Low

SWOT Analysis

Puma biotech Inc Live Price Chart